Literature DB >> 15694827

Current management of esophageal cancer.

Simon Law1, John Wong.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15694827     DOI: 10.1016/j.gassur.2004.06.007

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  170 in total

1.  Late course accelerated fractionation in radiotherapy of esophageal carcinoma.

Authors:  X H Shi; W Yao; T Liu
Journal:  Radiother Oncol       Date:  1999-04       Impact factor: 6.280

2.  Outcomes after esophagectomy: a ten-year prospective cohort.

Authors:  Stephen H Bailey; David A Bull; David H Harpole; Jeffrey J Rentz; Leigh A Neumayer; Theodore N Pappas; Jennifer Daley; William G Henderson; Barbara Krasnicka; Shukri F Khuri
Journal:  Ann Thorac Surg       Date:  2003-01       Impact factor: 4.330

3.  The radiotherapy of carcinoma of the oesophagus and post cricoid region in south east Scotland.

Authors:  J G Pearson
Journal:  Clin Radiol       Date:  1966-07       Impact factor: 2.350

4.  The cost effectiveness of metal oesophageal stenting in malignant disease compared with conventional therapy.

Authors:  D A Nicholson; A Haycox; C L Kay; A Rate; S Attwood; J Bancewicz
Journal:  Clin Radiol       Date:  1999-04       Impact factor: 2.350

5.  Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis.

Authors:  J B Hulscher; J G Tijssen; H Obertop; J J van Lanschot
Journal:  Ann Thorac Surg       Date:  2001-07       Impact factor: 4.330

6.  Localization of recurrent disease after extended lymph node dissection for carcinoma of the thoracic esophagus.

Authors:  T Matsubara; M Ueda; T Takahashi; T Nakajima; M Nishi
Journal:  J Am Coll Surg       Date:  1996-04       Impact factor: 6.113

7.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

8.  Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy.

Authors:  N T Nguyen; D M Follette; B M Wolfe; P D Schneider; P Roberts; J E Goodnight
Journal:  Arch Surg       Date:  2000-08

9.  Association between body mass and adenocarcinoma of the esophagus and gastric cardia.

Authors:  J Lagergren; R Bergström; O Nyrén
Journal:  Ann Intern Med       Date:  1999-06-01       Impact factor: 25.391

10.  Risk analysis in resection of squamous cell carcinoma of the esophagus.

Authors:  S Y Law; M Fok; J Wong
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

View more
  13 in total

1.  The effects of neoadjuvant chemoradiation on pTNM staging and its prognostic significance in esophageal cancer.

Authors:  Simon Law; Dora L W Kwong; Kam-Ho Wong; Ka-Fai Kwok; John Wong
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

2.  Clinical relevance of Fas expression in oesophageal squamous cell carcinoma.

Authors:  K W Chan; P Y Lee; A K Y Lam; S Law; J Wong; G Srivastava
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

Review 3.  Effect of preoperative single-dose corticosteroid administration on postoperative morbidity following esophagectomy.

Authors:  Edgard Engelman; Cécile Maeyens
Journal:  J Gastrointest Surg       Date:  2010-03-13       Impact factor: 3.452

4.  Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE).

Authors:  Philip W Y Chiu; Angus C W Chan; S F Leung; H T Leong; K H Kwong; Micheal K W Li; Alex C M Au-Yeung; Sydney C S Chung; Enders K W Ng
Journal:  J Gastrointest Surg       Date:  2005 Jul-Aug       Impact factor: 3.452

5.  Comparison of the outcomes between open and minimally invasive esophagectomy.

Authors:  Bernard M Smithers; David C Gotley; Ian Martin; Janine M Thomas
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

6.  Clinical value of lymph node dissection for stage T1b mid-thoracic esophageal squamous cell carcinoma.

Authors:  Xiaofeng Chen; Yujie Chen; Feng Wang; Shuoyan Liu; Peng Chen; Hao He
Journal:  J Gastrointest Oncol       Date:  2021-08

7.  Hugl-1 induces apoptosis in esophageal carcinoma cells both in vitro and in vivo.

Authors:  Jia Song; Xiu-Lan Peng; Meng-Yao Ji; Ming-Hua Ai; Ji-Xiang Zhang; Wei-Guo Dong
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

8.  Management of oesophageal cancer.

Authors:  Daniel K H Tong; Simon Law
Journal:  Indian J Surg       Date:  2010-01-13       Impact factor: 0.656

9.  PRAF3 induces apoptosis and inhibits migration and invasion in human esophageal squamous cell carcinoma.

Authors:  Guo-Zhen Shi; Yang Yuan; Guo-Jun Jiang; Zhi-Jun Ge; Jian Zhou; De-Jun Gong; Jing Tao; Yong-Fei Tan; Sheng-Dong Huang
Journal:  BMC Cancer       Date:  2012-03-21       Impact factor: 4.430

10.  New and emerging combination therapies for esophageal cancer.

Authors:  Marcus W Wiedmann; Joachim Mössner
Journal:  Cancer Manag Res       Date:  2013-06-27       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.